• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2009-2011 年台湾地区奥司他韦耐药甲型 H1N1pdm09 流感病毒的特征。

Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.

机构信息

Centers for Disease Control, Taipei, Taiwan.

出版信息

J Med Virol. 2013 Mar;85(3):379-87. doi: 10.1002/jmv.23482. Epub 2012 Dec 21.

DOI:10.1002/jmv.23482
PMID:23280715
Abstract

The early isolated swine-origin influenza A(H1N1)pdm09 viruses were susceptible to oseltamivir; however, there is a concern about whether oseltamivir-resistant influenza A(H1N1)pdm09 viruses will spread worldwide as did the oseltamivir-resistant seasonal influenza A(H1N1) viruses in 2007-2008. In this study, the frequency of oseltamivir resistance in influenza A(H1N1)pdm09 viruses was determined in Taiwan. From May 2009 to April 2011, 1,335 A(H1N1)pdm09-positive cases in Taiwan were tested for the H275Y mutation in the neuraminidase (NA) gene that confers resistance to oseltamivir. Among these, 15 patients (1.1%) were found to be infected with H275Y virus. All the resistant viruses were detected after the patients have received the oseltamivir. The overall monthly ratio of H275Y-harboring viruses ranged between 0% and 2.88%, and the peak was correlated with influenza epidemics. The genetic analysis revealed that the oseltamivir-resistant A(H1N1)pdm09 viruses can emerged from different variants with a great diversity under drug pressure. The ratio of NA/HA activities in different clades of oseltamivir-resistant viruses was reduced compared to those in the wild-type viruses, indicating that the balance of NA/HA in the current oseltamivir-resistant influenza A(H1N1)pdm09 viruses was interfered. It is possible that H275Y-bearing A(H1N1)pdm09 virus has not yet spread globally because it lacks the essential permissive mutations that can compensate for the negative impact on fitness by the H275Y amino acid substitution in NA. Continuous monitoring the evolution patterns of sensitive and resistant viruses is required to respond to possible emergence of resistant viruses with permissive genetic background which enable the wide spread of resistance.

摘要

从 2007-2008 年具有抗药性的季节性流感 A(H1N1)病毒在全球传播以来,人们一直担心是否具有抗药性的甲型 H1N1 流感病毒会在全球传播。本研究旨在确定台湾地区甲型 H1N1pdm09 流感病毒对奥司他韦的耐药频率。2009 年 5 月至 2011 年 4 月,对台湾地区 1335 例甲型 H1N1pdm09 阳性病例进行了神经氨酸酶(NA)基因 H275Y 突变检测,该突变可导致对奥司他韦的耐药性。其中,有 15 例(1.1%)患者感染了 H275Y 病毒。所有耐药病毒均在患者接受奥司他韦治疗后检出。H275Y 病毒携带株的总体月检出率介于 0%和 2.88%之间,高峰与流感流行相关。遗传分析显示,奥司他韦耐药的甲型 H1N1pdm09 病毒可以在药物压力下从不同的变体中产生,多样性很大。与野生型病毒相比,耐药病毒 NA/HA 活性的比值降低,表明当前奥司他韦耐药的甲型 H1N1pdm09 病毒中 NA/HA 的平衡受到干扰。具有 H275Y 氨基酸取代的奥司他韦耐药甲型 H1N1pdm09 病毒尚未在全球传播,可能是因为它缺乏必要的许可突变,这些突变可以补偿 NA 中的 H275Y 氨基酸取代对适应性的负面影响。需要对敏感和耐药病毒的进化模式进行持续监测,以应对具有许可遗传背景的耐药病毒的出现,从而使其广泛传播。

相似文献

1
Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.2009-2011 年台湾地区奥司他韦耐药甲型 H1N1pdm09 流感病毒的特征。
J Med Virol. 2013 Mar;85(3):379-87. doi: 10.1002/jmv.23482. Epub 2012 Dec 21.
2
Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.台湾地区发现对奥司他韦耐药的大流行(H1N1)2009 流感 A 病毒的早期结果。
Antiviral Res. 2010 Dec;88(3):256-62. doi: 10.1016/j.antiviral.2010.09.014. Epub 2010 Sep 24.
3
Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.神经氨酸酶的适应性变化在提高对奥司他韦耐药的季节性甲型H1N1流感病毒株的病毒适应性方面起主导作用。
Antiviral Res. 2015 Feb;114:57-61. doi: 10.1016/j.antiviral.2014.12.006. Epub 2014 Dec 12.
4
Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.2013 - 2014年中国大陆流感季节期间甲型H1N1pdm09流感病毒对奥司他韦耐药的特征
Virol J. 2015 Jun 24;12:96. doi: 10.1186/s12985-015-0317-1.
5
Allele-specific conventional reverse-transcription polymerase chain reaction as a screening assay for discriminating influenza a H1N1 (H275Y) oseltamivir-resistant and wild-type viruses.用于区分流感 A H1N1(H275Y)奥司他韦耐药和野生型病毒的等位基因特异性常规逆转录聚合酶链反应筛选检测法。
J Med Virol. 2010 Aug;82(8):1295-8. doi: 10.1002/jmv.21783.
6
Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.预测能够改善携带 H275Y 神经氨酸酶取代的 A(H1N1)pdm09 病毒适应性的许可性突变。
J Virol. 2022 Aug 10;96(15):e0091822. doi: 10.1128/jvi.00918-22. Epub 2022 Jul 14.
7
A two-year survey of the oseltamivir-resistant influenza A(H1N1) virus in Yamagata, Japan and the clinical effectiveness of oseltamivir and zanamivir.日本山形县奥司他韦耐药性甲型 H1N1 流感病毒的两年监测及奥司他韦和扎那米韦的临床疗效。
Virol J. 2010 Mar 5;7:53. doi: 10.1186/1743-422X-7-53.
8
Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.检测与奥司他韦耐药相关的 H275Y 突变在严重大流行流感病毒 A/H1N1 09 感染中的快速出现。
Antiviral Res. 2010 Jul;87(1):16-21. doi: 10.1016/j.antiviral.2010.04.002. Epub 2010 Apr 10.
9
Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.2015 年印度与高病死率相关的耐奥司他韦的甲型 H1N1 流感病毒
J Med Virol. 2018 May;90(5):836-843. doi: 10.1002/jmv.25013. Epub 2018 Feb 9.
10
Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.宿主细胞对流感神经氨酸酶变体的选择:对 A(H1N1)病毒药物耐药性监测的影响。
Antiviral Res. 2010 Feb;85(2):381-8. doi: 10.1016/j.antiviral.2009.11.005. Epub 2009 Nov 13.

引用本文的文献

1
A highly efficient and accurate method of detecting and subtyping Influenza A pdm H1N1 and H3N2 viruses with newly emerging mutations in the matrix gene in Eastern Taiwan.一种在台湾东部检测和细分具有新型基质基因突变的甲型流感 pdm H1N1 和 H3N2 病毒的高效、准确方法。
PLoS One. 2023 Mar 23;18(3):e0283074. doi: 10.1371/journal.pone.0283074. eCollection 2023.
2
Use of lentiviral pseudotypes as an alternative to reassortant or Triton X-100-treated wild-type Influenza viruses in the neuraminidase inhibition enzyme-linked lectin assay.在神经氨酸酶抑制酶联凝集素测定中,使用慢病毒假型作为替代重组或 Triton X-100 处理的野生型流感病毒。
Influenza Other Respir Viruses. 2019 Sep;13(5):504-516. doi: 10.1111/irv.12669.
3
Containing influenza outbreaks with antiviral use in long-term care facilities in Taiwan, 2008-2014.
2008-2014 年台湾地区长期护理机构中使用抗病毒药物控制流感爆发的情况。
Influenza Other Respir Viruses. 2018 Mar;12(2):287-292. doi: 10.1111/irv.12536. Epub 2018 Jan 28.
4
Rapid control of pandemic H1N1 influenza by targeting NKT-cells.通过靶向 NKT 细胞快速控制大流行性 H1N1 流感。
Sci Rep. 2016 Nov 29;6:37999. doi: 10.1038/srep37999.
5
A Potent Anti-influenza Compound Blocks Fusion through Stabilization of the Prefusion Conformation of the Hemagglutinin Protein.一种强效抗流感化合物通过稳定血凝素蛋白的预融合构象来阻断融合。
ACS Infect Dis. 2015 Feb 13;1(2):98-109. doi: 10.1021/id500022h. Epub 2014 Dec 15.
6
Molecular findings from influenza A(H1N1)pdm09 detected in patients from a Brazilian equatorial region during the pandemic period.在大流行期间,对来自巴西赤道地区患者中检测到的甲型H1N1pdm09流感病毒进行的分子研究结果。
Mem Inst Oswaldo Cruz. 2014 Nov;109(7):912-7. doi: 10.1590/0074-0276140210. Epub 2014 Oct 14.
7
Model-based simulation and prediction of an antiviral strategy against influenza A infection.基于模型的模拟和预测抗甲型流感病毒感染的抗病毒策略。
PLoS One. 2013 Jul 9;8(7):e68235. doi: 10.1371/journal.pone.0068235. Print 2013.